Lemaitre Vascular (LMAT) Net Shares Issued and Repurchased (2012 - 2025)
Lemaitre Vascular's (LMAT) quarterly Net Shares Issued and Repurchased came in at $179830.0 in Q4 2025, up 42.91% year-over-year from $125834.0 in Q4 2024, and up 24168.56% quarter-over-quarter from $741.0 in Q1 2025.
Powered by 
Analysis
Lemaitre Vascular (LMAT) Net Shares Issued and Repurchased (2012 - 2025) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Net Shares Issued and Repurchased for 14 consecutive years, with $179830.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased rose 42.91% year-over-year to $179830.0 in Q4 2025; TTM through Dec 2025 was $179830.0, a 42.91% increase from a year earlier, with the FY2025 full-year figure at $179830.0, up 42.91% from the prior year.
- Net Shares Issued and Repurchased was $179830.0 for Q4 2025 at Lemaitre Vascular, up from $741.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $179830.0 in Q4 2025 and troughed at $200.0 in Q1 2023.
- A 5-year average of $110467.1 and a median of $148115.0 in 2023 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased retreated 15.04% in 2024 and surged 42.91% in 2025, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $159275.0 in 2021, then changed by 0.0% to $159275.0 in 2022, then slipped by 7.01% to $148115.0 in 2023, then dropped by 15.04% to $125834.0 in 2024, then jumped by 42.91% to $179830.0 in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $179830.0 (Q4 2025), $741.0 (Q1 2025), and $125834.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 179,830.00 |
| Mar 31, 2025 | 741.00 |
| Dec 31, 2024 | 125,834.00 |
| Dec 31, 2023 | 148,115.00 |
| Mar 31, 2023 | 200.00 |
| Dec 31, 2022 | 159,275.00 |
| Dec 31, 2021 | 159,275.00 |
| Dec 31, 2020 | 151,161.00 |
| Dec 31, 2019 | 195,379.00 |
| Dec 31, 2018 | 280,423.00 |
| Dec 31, 2017 | 219,413.00 |
| Dec 31, 2016 | 510,745.00 |
| Dec 31, 2015 | 511,227.00 |
| Dec 31, 2014 | 508,537.00 |
| Dec 31, 2013 | 367,277.00 |
| Dec 31, 2012 | 304,172.00 |